Tanke Biosciences Corp

TNBI OTC SEC CIK 1452011
Follow Tanke Biosciences Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2012 USD · US GAAP
Revenue, last year $28.6M +19.8% vs prior year
Net income −$210.2K +93.3% vs prior year
EPS, diluted −$0.02 +91.7% vs prior year
Operating cash flow −$1.2M −132.4% vs prior year
Revenue by fiscal year
$20.1M
$23.8M
$28.6M
FY10 FY11 FY12

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$10M$0$10M$20M$30MFY08FY09FY10FY11FY12
Show the numbers
YearRevenueNet income
FY12$28.6M−$210.2K
FY11$23.8M−$3.1M
FY10$20.1M$2.7M
FY09-$2.6M
FY08--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%FY08FY09FY10FY11FY12
Show the numbers
YearGross marginOperating marginNet margin
FY1234.8%15.9%−0.7%
FY1136.8%7.3%−13.2%
FY1036.8%21.8%13.6%
FY09---
FY08---
Free cash flowOperating cash flow minus capital expenditure
−$4M−$2M$0$2M$4M$6MFY08FY09FY10FY11FY12
Show the numbers
YearFree cash flow
FY12−$2M
FY11$3M
FY10$4.3M
FY09-
FY08-